Armata Pharmaceuticals, Inc. Share Price
ARMPArmata Pharmaceuticals, Inc. Stock Performance
Open $8.13 | Prev. Close $7.96 | Circuit Range N/A |
Day Range $8.06 - $8.13 | Year Range $1.76 - $16.34 | Volume 578 |
Average Traded $8.09 |
Armata Pharmaceuticals, Inc. Share Price Chart
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
19-May-26 | $7.18 | $8.29 | +8.44% |
18-May-26 | $8.00 | $7.64 | -5.84% |
15-May-26 | $8.30 | $8.12 | -8.26% |
14-May-26 | $8.62 | $8.85 | -1.99% |
13-May-26 | $9.03 | $9.03 | +0.28% |
12-May-26 | $8.28 | $9.01 | +0.45% |
11-May-26 | $8.46 | $8.96 | +4.30% |